Clinical Trial Update: DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in CTO. [NA]

View source ↗

Summary

Clinical trial update evaluating dissection re-entry using Absorb bioresorbable vascular scaffolds in chronic total occlusion of the coronary arteries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Total Occlusion

Drugs mentioned

• Absorb Bioresorbable Vascular Scaffold (bioresorbable vascular scaffold)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN